Monica P.
- Country
- Romania
- Department
- Medical Oncology
Research Overview
- Evaluation of Adagrasib Dosing Regimens in Previously Treated KRAS G12C-Mutant Non-Small Cell Lung Cancer Patients
- Phase III Randomized Double-Blind Study of Durvalumab and Domvanalimab in Stage III Unresectable NSCLC Post-Platinum-Based Chemoradiation Therapy
- Evaluation of ABP 206 Versus Nivolumab in Treatment-Naïve Patients with Unresectable or Metastatic Melanoma
Data & Insights
Has run more than one trial at 50 of 332 partner sites.
Specializations
Breast Cancer Research
Specialized focus on hormone receptor-positive (ER+) and HER2-negative breast cancer treatment approaches, particularly investigating extended endocrine therapy strategies for early-stage disease.
- Adjuvant Endocrine Therapy
- Breast Cancer Recurrence Prevention
Active investigation of novel therapeutic agents for improving long-term outcomes in breast cancer patients.
Lung Cancer Innovation
Expertise in treating advanced non-small cell lung cancer (NSCLC), with particular emphasis on unresectable Stage III disease and novel therapeutic combinations.
- Immunotherapy Combinations
- Targeted KRAS G12C Therapies
- Chemoradiation Protocols
Focus on personalized treatment approaches utilizing biomarker-driven patient selection.
Precision Oncology
Dedicated to advancing biomarker-guided treatment strategies in thoracic oncology, including PD-L1 expression and specific genetic mutations.
- Molecular Testing Applications
- Treatment Response Assessment
- Novel Drug Development
Integration of innovative therapeutic approaches for both early-stage and metastatic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.